The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Is cancer associated thrombosis (CAT) a neglected issue? Greek management of thrombosis (GMaT) in cancer patients.
 
Nikolaos Tsoukalas
No Relationships to Disclose
 
Pavlos Papakotoulas
No Relationships to Disclose
 
Athina Christopoulou
No Relationships to Disclose
 
Alexandros Ardavanis
No Relationships to Disclose
 
Georgios Koumakis
No Relationships to Disclose
 
Christos Papandreou
No Relationships to Disclose
 
George Papatsibas
No Relationships to Disclose
 
Pavlos Papakostas
No Relationships to Disclose
 
Charalampos Andreadis
No Relationships to Disclose
 
Gerasimos Aravantinos
No Relationships to Disclose
 
Nikolaos Ziras
No Relationships to Disclose
 
Charalambos P. Kalofonos
No Relationships to Disclose
 
Epaminontas Samantas
No Relationships to Disclose
 
Sougleri Maria
No Relationships to Disclose
 
Paris Makrantonakis
No Relationships to Disclose
 
George E. Pentheroudakis
No Relationships to Disclose
 
Athanasios Athanasiadis
No Relationships to Disclose
 
Evangelos Bournakis
No Relationships to Disclose
 
Ioannis I. Varthalitis
No Relationships to Disclose
 
Ioannis Boukovinas
Employment - Novartis Pharmaceuticals UK Ltd. (I)
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; LEO Pharma; MSD; Novartis; Roche; Sanofi
Research Funding - Bristol-Myers Squibb; MSD; Novartis; Regeneron; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Pfizer; Roche